News By Tag
News By Location
Follow on Google News
Journey Medical Corp Announces New Journey with the Experts Video Featuring Pantea Tamjidi, MD
Dr. Tamjidi discusses seborrheic keratosis, a common skin growth affecting nearly 83 million Americans
According to the Mayo Clinic, seborrheic keratosis is a common noncancerous skin condition that appears as a waxy black, brown, or tan growth. Seborrheic keratoses usually appear on the face, neck, chest, or back and are not contagious. To view the Journey with the Experts video featuring Dr. Tamjidi, please visit https://vimeo.com/
About Journey with the Experts
Journey with the Experts is an educational initiative supported by Journey Medical Corporation, the medical dermatology company. The initiative is designed to educate the general public on common medical dermatology skin disorders and explain how these conditions can be treated at local dermatology practices.
The information, including, without limitation, topics, presentations, discussions, content, descriptions or any other material contained herein is for informational purposes only. None of the material herein is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified HCP with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay seeking it because of something you have heard, observed, or inferred herein. Any reliance is strictly prohibited.
About Journey Medical Corporation
Journey Medical (NASDAQ:DERM)
About Pantea Tamjidi, MD, FAAD
Dr. Tamjidi is a well-respected, board-certified dermatologist offering a broad spectrum of medical and cosmetic procedures. She is a recognized Washington, DC-area leader in the latest anti-aging skin techniques and dermal fillers. She received her medical degree from the George Washington University Medical School, and Washingtonian Magazine named Dr. Tamjidi a "Top Doctor" in the Washington, DC Metropolitan area. For additional information about Dr. Tamjidi, please visit https://www.tamjidiskininstitute.com/
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. As used below and throughout this press release, the words "we", "us" and "our" may refer to Journey Medical. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships;
Jaclyn Jaffe and Bill Begien